Driehaus Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-201,566
| Closed | -$5.1M | – | 456 |
|
|
2023
Q2 | $5.1M | Buy |
+201,566
| New | +$5.1M | 0.06% | 271 |
|
|
2021
Q4 | – | Sell |
-381,302
| Closed | -$10.6M | – | 457 |
|
|
2021
Q3 | $10.6M | Buy |
381,302
+174,294
| +84% | +$4.86M | 0.13% | 220 |
|
|
2021
Q2 | $6.14M | Sell |
207,008
-3,395
| -2% | -$101K | 0.08% | 268 |
|
|
2021
Q1 | $5.88M | Sell |
210,403
-16,062
| -7% | -$449K | 0.09% | 268 |
|
|
2020
Q4 | $6.42M | Sell |
226,465
-356,898
| -61% | -$10.1M | 0.1% | 224 |
|
|
2020
Q3 | $14.7M | Sell |
583,363
-166,067
| -22% | -$4.17M | 0.3% | 97 |
|
|
2020
Q2 | $18.3M | Buy |
749,430
+8,652
| +1% | +$211K | 0.45% | 63 |
|
|
2020
Q1 | $11M | Buy |
740,778
+84,765
| +13% | +$1.25M | 0.37% | 77 |
|
|
2019
Q4 | $10.6M | Buy |
+656,013
| New | +$10.6M | 0.28% | 97 |
|
|
2016
Q2 | – | Sell |
-117,168
| Closed | -$2.05M | – | 635 |
|
|
2016
Q1 | $2.05M | Buy |
117,168
+39,090
| +50% | +$683K | 0.07% | 279 |
|
|
2015
Q4 | $2.67M | Buy |
+78,078
| New | +$2.67M | 0.09% | 247 |
|
|
2014
Q4 | – | Sell |
-74,289
| Closed | -$1.44M | – | 602 |
|
|
2014
Q3 | $1.44M | Sell |
74,289
-192,765
| -72% | -$3.73M | 0.05% | 389 |
|
|
2014
Q2 | $9.08M | Sell |
267,054
-1,464
| -0.5% | -$49.8K | 0.29% | 78 |
|
|
2014
Q1 | $8.46M | Buy |
+268,518
| New | +$8.46M | 0.27% | 90 |
|